United States

Nektar Therapeutics is a biopharmaceutical company that develops medicines for unmet medical needs. Its products include Bempegaldesleukin, NKTR-358, NKTR-255, and NKTR-262, which are in various stages of clinical trials for the treatment of cancer, autoimmune diseases, and COVID-19. The company has collaboration agreements with several pharmaceutical companies. Nektar Therapeutics was founded in 1990 and is based in San Francisco, California.

Nektar Therapeutics

Biopharmaceutical company developing medicines.

Google

Vörustjóri

Gagnafræðingur

Nektar Therapeutics

Nektar Therapeutics Opin Störf

Ertu tilbúinn að efla ferilinn þinn? Skoðaðu þessi opnu störf hjá Nektar Therapeutics.